Marco Pio La Manna obtained his degree with honors in Biological Sciences in 1998 at the University of Palermo. He obtained a PhD in Immunopharmacology in 2006 and specialized in Clinical Pathology with honors in 2016 at the University of Palermo. He was a postdoctoral fellow from 2006 to 2010 at the department of Biopathology Biomedical Methodologies University of Palermo. He was also a postdoctoral fellow from 2014 to 2015 at the Department of Molecular Medicine University of Rome Sapienza. and a postdoctoral fellow from 2016 to 2019 at Central Laboratory for Advanced Diagnosis and Biomedical Research (CLADIBIOR) Polyclinic Hospital of Palermo. Since 2020, he has been a researcher at the department of Biomedicine Neuroscience and Advanced Diagnostic (BIND) University of Palermo. His research activity covered innate and adaptive immune responses against Mycobacterium tuberculosis and other pathogens in humans and animals and the study of T and B cells in autoimmune diseases and hematological malignancies. He has published over 40 papers in peer-reviewed scientific journals and participated in the Horizon 2020 project: "Eliciting Mucosal Immunity to Tuberculosis (EMI-TB)", funded by the European Union.